Stallergenes Inh. buy melinda
Start price
27.08.10
/
50%
€57.29
Target price
28.02.11
€63.00
Performance (%)
2.79%
End price
28.02.11
€58.89
Summary
This prediction ended on 28.02.11 with a price of €58.89. With a performance of 2.79%, the BUY prediction by melinda for Stallergenes Inh. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Stallergenes Inh. | - | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by melinda for this prediction
In the thread Stallergenes Inh. diskutieren
Biopharma-
Stallergenes ist ein biopharmazeutisches Labor in Europa, spezialisiert auf die Behandlung von Atemwegserkrankungen, Asthma Nashorn
(Laufzeit überschritten)
